Digest Network Come funziona
Network
/
Società
Co
Non verificato

Cosette Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIgiene alimentareIndustriaSalute

12 comunicati stampa

Guarda tutti i comunicati
20/10/2026
Multimedialità
Biotecnologia
Igiene alimentare
Farmaceutica
Salute
Industria
Cosette Pharmaceuticals Announces FDA Approval of EVOXAC® (cevimeline HCl) Oral Solution, Marking Cosette’s First New Drug Application (NDA) Approval
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
10/09/2026
Cosette Appoints Andrew Adams as Vice President, Supply Chain & Sourcing
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
19/05/2026
Biotecnologia
Sanità
Farmaceutica
Salute
Mercato del lavoro
Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands)
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
29/04/2026
Cosette Pharmaceuticals Appoints Erika Tooman as Senior Vice President, General Counsel, Strengthening Leadership Team to Drive Accelerated Growth and Strategic Expansion
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
08/04/2026
Mercato azionario
Industria
Salute
Igiene alimentare
Sanità
Farmaceutica
Biotecnologia
Cosette Pharmaceuticals Expands Branded Portfolio through Acquisition of SYMPAZAN® and Additional Products from Assertio
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
16/12/2025
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therapy (CGT) exclusivity
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
11/12/2025
Mercato azionario
Salute
Farmaceutica
Termination of Proposed Acquisition of Mayne Pharma
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
30/06/2025
Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
20/02/2025
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women’s Health and Dermatology
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
10/02/2025
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations
Fonte
Cosette Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0